← Back to all trials
Not Yet Recruiting
NCT05643001
Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke
Conditions: Hemorrhagic Stroke
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 400
Sponsor: Massachusetts General Hospital
Location: United States
Summary
The overall goal of this study is to increase health care provider awareness for common risk factors and comorbidities in patients with hemorrhagic stroke that are related to impaired brain health, to ultimately improve patients management and associated outcomes.
The specific objective is to test the performance and effectiveness of a custom electronic health record (EHR)-based notification module at time of index hospitalization and at follow-up for hemorrhagic stroke survivors, before disparities in access to outpatient care may limit opportunities to intervene.The investigators hypothesize that notification of health care providers through the EHR will increase measurements of low-density lipoprotein (LDL) and glycated hemoglogbin A1c (HbA1c) and increase evaluation and management rates for obstructive sleep apnea and hearing impairment.
Eligibility Criteria
Inclusion Criteria:Patients aged 18 years or olderPresenting with a primary diagnosis of hemorrhagic stroke admitted to Massachusetts General Hospital inpatient stroke serviceExclusion Criteria:Patients not meeting above inclusion criteriaPatients presenting with subdural or epidural hematoma
Source: ClinicalTrials.gov (NCT05643001). StuddyBuddy aggregates publicly available trial information.